Valuation Vertex Pharmaceuticals Incorporated Buenos Aires S.E.

Stocks

End-of-day quote Buenos Aires S.E. 2026-10-28			5-day change	1st Jan Change
8,720.00 ^ARS	+2.65%		+2.95%	+27.49%

10-28	ConvaTec to Spend GBP500 Million on New Global R&D Hub in Manchester, England, Over Next Decade	MT
10-23	Vertex Pharmaceuticals Incorporated Presents at American Society of Nephrology Kidney Week 2026, Oct-23-2026 06:15 PM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	134,256	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	16.72%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	126,552	124,239	121,481
Change	-	31.13%	47.8%	4.23%	11.09%	16.73%	-1.83%	-2.22%
P/E	24.4x	22.5x	29.3x	-194x	29.6x	50.2x	28.5x	23.4x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	7.74x	6.25x	5.1x
PEG	-	0.5x	3.51x	2x	-0x	-1.6x	0.4x	1.1x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	10.1x	9.2x	8.1x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	9.53x	8.51x	7.33x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	26.7x	19.5x	16.4x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	22.6x	20.3x	16.6x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	70.2x	26.2x	23.5x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	1.43%	3.82%	4.25%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	10.56	18.59	22.68
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,276	14,598	16,566
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	4,746	6,367	7,421
EBIT ¹	4,344	4,793	4,375	695.6	5,263	5,611	6,129	7,322
Net income ¹	2,342	3,322	3,620	-535.6	3,953	3,451	4,903	5,892
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-7,704	-10,017	-12,775
Reference price ²	219.60	288.78	406.89	402.70	453.36	529.69	529.69	529.69
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,461	-	-
Announcement Date	1/26/22	2/7/23	2/5/24	2/10/25	2/12/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,143B
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	647B
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	506B
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	384B
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	350B
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	293B
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	265B
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	242B
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	197B
Average	29.58x	7.09x	18.77x	2.12%	447.5B
Weighted average by Cap.	35.27x	8.35x	20.48x	1.8%